Antares Pharma, Inc. ATRS
5.59 +5.59
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 183.98M | 149.60M | 123.86M | 63.55M | 54.52M | |
| 129.56M | 95.64M | 77.60M | 34.46M | 27.05M | |
| 79.80M | 22.76M | 5.20M | -2.13M | -15.59M | |
| 46.29M | 56.20M | -2.03M | -6.51M | -16.74M | |
| 0.26 | 0.33 | -0.01 | -0.04 | -0.11 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 65.91M | 53.14M | 23.20M | 27.89M | 26.56M | |
| 257.50M | 212.53M | 132.75M | 88.28M | 74.34M | |
| 81.75M | 93.42M | 78.25M | 49.28M | 40.79M | |
| 25.22M | 46.92M | 47.09M | 25.13M | 24.86M | |
| 175.76M | 119.11M | 54.50M | 39.00M | 33.55M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 36.62M | 21.32M | -10.62M | -17.32M | -23.09M | |
| -3.85M | 8.17M | -20.00M | 11.61M | -4.33M | |
| -19.99M | 447.00K | 25.92M | 7.04M | 26.27M | |
| 11.21M | -9.33M | 2.65M | 6.65M | 734.00K | |
| 12.78M | 29.94M | -4.69M | 1.33M | -1.15M |